{"gene":"MRAP2","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":2009,"finding":"MRAP2 interacts with all five melanocortin receptors (MC1R–MC5R). This interaction enables MC2R surface expression and signaling, while reducing MC1R, MC3R, MC4R, and MC5R responsiveness to NDP-MSH — establishing MRAP2 as a bidirectional regulator of the MCR family.","method":"Co-immunoprecipitation, cell surface expression assays, cAMP signaling assays in heterologous cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction and functional readouts replicated across all five receptors in a highly-cited foundational paper","pmids":["19329486"],"is_preprint":false},{"year":2013,"finding":"In zebrafish, MRAP2a binds MC4R and reduces ligand binding affinity for α-MSH, thereby blocking MC4R activity and stimulating growth during larval development, while MRAP2b also binds MC4R but increases ligand sensitivity, enhancing responsiveness to α-MSH once feeding begins — demonstrating developmental control of MC4R by MRAP2 isoforms.","method":"Zebrafish genetic model, cell culture binding and signaling assays, in vivo growth phenotyping","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — in vitro binding and signaling combined with in vivo zebrafish genetic evidence, highly cited","pmids":["23869017"],"is_preprint":false},{"year":2017,"finding":"MRAP2 interacts with the ghrelin receptor GHSR1a and potentiates ghrelin-stimulated G protein signaling both in vitro and in vivo. In MRAP2-deficient mice, fasting fails to activate AgRP neurons and the orexigenic effect of ghrelin is lost.","method":"Co-immunoprecipitation (MRAP2–GHSR1a interaction), in vitro cAMP/signaling assays, MRAP2 knockout mouse model with neuronal activation readout","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — interaction confirmed by Co-IP, functional consequence demonstrated in vitro and in vivo with KO mice","pmids":["28959025"],"is_preprint":false},{"year":2017,"finding":"MRAP2 interacts with and inhibits the trafficking and signaling of orexin receptor 1 (OX1R) and prokineticin receptor 1 (PKR1). Specific regions of MRAP2 are required for regulation of OX1R and PKR1.","method":"Co-immunoprecipitation, cell surface trafficking assays, domain-mapping experiments with MRAP2 truncation mutants","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 2 — interaction and domain mapping shown in vitro; single lab","pmids":["28939058"],"is_preprint":false},{"year":2020,"finding":"MRAP2 inhibits the constitutive activity of GHSR1a, enhances G protein-dependent (Gαq) signaling in response to ghrelin, and blocks β-arrestin recruitment and signaling. The effects on Gαq and β-arrestin pathways involve distinct regions of MRAP2, establishing biased signaling modulation by an accessory protein.","method":"Gαq and β-arrestin signaling assays, domain-mapping of MRAP2, constitutive activity assays in heterologous cells","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal signaling assays with domain-mapping mutagenesis in a single rigorous study","pmids":["31911434"],"is_preprint":false},{"year":2020,"finding":"MRAP2 is expressed in pancreatic islet δ cells and is required for ghrelin to elicit a calcium response in those cells. Global and δ-cell-targeted deletion of MRAP2 abrogates the insulinostatic effect of ghrelin, establishing MRAP2 as a regulator of insulin secretion via δ-cell GHSR1a signaling.","method":"Calcium imaging in δ cells, global and conditional (δ cell-specific) MRAP2 knockout mouse models, insulin secretion assays","journal":"iScience","confidence":"High","confidence_rationale":"Tier 2 — clean conditional KO with specific cellular and physiological phenotype using multiple mouse models","pmids":["32535024"],"is_preprint":false},{"year":2022,"finding":"MRAP2 inhibits β-arrestin recruitment to GHSR1a by blocking GRK2 and PKC from phosphorylating the receptor at Ser252 and Thr261 in the third intracellular loop. The C-terminal tail of GHSR1a is not essential for β-arrestin interaction.","method":"Phosphorylation site mutagenesis, GRK2/PKC interaction assays, β-arrestin recruitment assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — active-site/phosphorylation-site mutagenesis with mechanistic follow-up identifying the kinases blocked by MRAP2","pmids":["35605660"],"is_preprint":false},{"year":2022,"finding":"Arginine 125 in MRAP2 is essential for protein conformation, dimer formation, and PKR2 binding. Human obesity-associated mutations R125H and R125C disrupt these functions.","method":"MRAP2 mutant characterization (R125H, R125C), dimerization assays, PKR2 co-immunoprecipitation, comparison with mouse MRAP2","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with functional readouts; single lab","pmids":["36077245"],"is_preprint":false},{"year":2022,"finding":"MRAP2 interacts with melanin-concentrating hormone receptor 1 (MCHR1) as shown by co-immunoprecipitation and bimolecular fluorescence complementation, and inhibits MCHR1 signaling. The C-terminal domain of MRAP2 is required for pharmacological modulation of intracellular Ca2+ cascades and membrane transport of MCHR1.","method":"Co-immunoprecipitation, BiFC assay, functional truncation mapping, intracellular Ca2+ signaling assay","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods confirming interaction and domain requirements; single lab","pmids":["35311242"],"is_preprint":false},{"year":2023,"finding":"MRAP2 is critical for the ciliary localization of MC4R in neurons. Loss of MRAP2 disrupts MC4R targeting to the primary cilium, and this ciliary localization is essential for the weight-regulating function of MC4R neurons and long-term energy homeostasis.","method":"Conditional mouse models (MRAP2 KO in MC4R neurons), live imaging/immunofluorescence of primary cilia localization, body weight and food intake phenotyping","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 — direct localization experiment with functional consequence demonstrated in vivo using conditional KO mice","pmids":["36692018"],"is_preprint":false},{"year":2024,"finding":"MRAP2 inhibits β-arrestin-2 recruitment to prokineticin receptor 2 (PKR2) without preventing receptor internalization, modulating PKR2-mediated β-arrestin signaling pathways.","method":"β-arrestin recruitment assays, receptor internalization assays, signaling pathway analysis","journal":"Current issues in molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 — defined molecular mechanism with clear readouts; single lab","pmids":["38392222"],"is_preprint":false},{"year":2025,"finding":"MRAP2 co-expression increases MC4R G protein-mediated signaling, impairs β-arrestin2 recruitment and receptor internalization, and disrupts MC4R oligomers, increasing the proportion of monomeric MC4R. A structural homology model identifies MRAP2 interaction sites relevant for receptor activation.","method":"cAMP signaling assays, β-arrestin2 recruitment assays, FRET/fluorescence-based oligomerization assays, structural homology modeling","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including structural model, signaling, and oligomerization assays in a single rigorous study","pmids":["40998819"],"is_preprint":false},{"year":2025,"finding":"MRAP2 directly interacts with MC3R with 1:1 stoichiometry, enhances MC3R cAMP signaling, impairs β-arrestin recruitment, and reduces MC3R internalization. Alanine mutagenesis of five MRAP2 and three MC3R transmembrane residues identified by structural homology modeling disrupts these effects. Obesity-associated MRAP2 variants fail to enhance MC3R signaling.","method":"Single-molecule pull-down (SiMPull), fluorescence photobleaching stoichiometry, cAMP assay, β-arrestin recruitment assay, internalization assay, transmembrane alanine mutagenesis, structural homology modeling","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1–2 — single-molecule interaction assays with stoichiometry, mutagenesis, and multiple functional readouts in peer-reviewed study","pmids":["41401256"],"is_preprint":false},{"year":2025,"finding":"MRAP2 interacts with MC4R, MC3R, and GHSR1a preferentially as 1:1 complexes (disrupting GPCR homodimerization), using shared receptor transmembrane region contacts to promote G protein signaling and impair β-arrestin-2 recruitment. Deletion of the MRAP2 cytoplasmic C-terminal region impairs GPCR signaling by modulating receptor constitutive activity. Obesity-associated MRAP2 variants modify constitutive activity of all three GPCRs.","method":"Single-molecule pull-down stoichiometry, GPCR homodimerization assays, domain deletion mutagenesis, constitutive activity assays, β-arrestin-2 recruitment assays for three receptors","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods across three receptors establishing conserved mechanism; rigorous domain mapping","pmids":["41722048"],"is_preprint":false},{"year":2025,"finding":"Obesity-associated MRAP2 variants impair multiple MC4R signaling pathways including Gs-cAMP and Gq-IP3; seven variants impair cAMP signaling and nine impair IP3 signaling. Four mutations in the MRAP2 C-terminus affect MC4R internalization. Structural models predict MRAP2 interacts with MC4R transmembrane helices 5 and 6, and mutagenesis of these contact sites impairs MRAP2-facilitated MC4R signaling.","method":"cAMP signaling assay, IP3 signaling assay, internalization assay, cell surface expression assay, structural homology modeling, contact-site alanine mutagenesis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 — comprehensive multi-pathway functional analysis with structural modeling and mutagenesis validation of 12 MRAP2 variants","pmids":["39807633"],"is_preprint":false},{"year":2018,"finding":"Overexpression of MRAP2 specifically in PVN MC4R-expressing neurons reduces food intake, increases energy expenditure, and enhances neuronal activation at baseline and after MC3R/MC4R agonist treatment, demonstrating a site-specific role for MRAP2 in potentiating MC4R signaling in the hypothalamic paraventricular nucleus.","method":"Stereotaxic AAV-mediated MRAP2 overexpression in Mc4r-cre mice (PVN-targeted), metabolic phenotyping (food intake, energy expenditure, glucose metabolism), c-Fos neuronal activation","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 2 — circuit-level gain-of-function with defined cellular target and multiple physiological readouts","pmids":["30352741"],"is_preprint":false},{"year":2025,"finding":"MRAP2 interacts with melatonin receptors MTNR1A and MTNR1B, inhibits their constitutive activity, and enhances maximal agonist potency. MRAP2 suppresses membrane trafficking of MTNR1A but promotes surface trafficking of MTNR1B.","method":"Co-immunoprecipitation, BiFC assay, GloSensor luminescence (Gi signaling), fixed-cell ELISA (surface expression)","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods for a novel receptor interaction; single lab","pmids":["40510472"],"is_preprint":false},{"year":2021,"finding":"MRAP2 forms a symmetric antiparallel homodimer topology on the plasma membrane. Inversion of individual MRAP2 domains (N-terminal, transmembrane, C-terminal) via chimeric constructs shows proper dimer assembly but alters regulatory profile on MC4R surface expression and ligand-stimulated cAMP signaling, demonstrating functional importance of domain orientation within the dimer.","method":"Chimeric domain-inversion constructs, cell surface expression assays, cAMP signaling assays, homodimer characterization","journal":"Frontiers in endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — domain-inversion mutagenesis with multiple functional readouts establishes topology-function relationship; single lab","pmids":["34759891"],"is_preprint":false}],"current_model":"MRAP2 is a single-pass transmembrane protein that forms antiparallel homodimers and interacts (predominantly as 1:1 complexes) with multiple GPCRs — including MC2R, MC3R, MC4R, GHSR1a, OX1R, PKR1/PKR2, MCHR1, and melatonin receptors — using shared transmembrane contact sites (e.g., MC4R TM5/6) to enhance G protein-mediated signaling, suppress β-arrestin recruitment (partly by blocking GRK2/PKC-mediated receptor phosphorylation), disrupt GPCR homodimerization, and in neurons promote MC4R targeting to primary cilia, with the C-terminal cytoplasmic region modulating constitutive GPCR activity; loss-of-function MRAP2 variants associated with human obesity disrupt these shared regulatory mechanisms across multiple receptor partners."},"narrative":{"teleology":[{"year":2009,"claim":"The question of whether MRAP2 regulates receptors beyond MC2R was answered: MRAP2 interacts with all five melanocortin receptors and bidirectionally modulates their signaling, establishing it as a general MCR accessory protein rather than an MC2R-specific chaperone.","evidence":"Co-immunoprecipitation, surface expression, and cAMP assays across MC1R–MC5R in heterologous cells","pmids":["19329486"],"confidence":"High","gaps":["Mechanism of differential regulation (facilitation of MC2R vs. inhibition of MC1R/MC3R–MC5R) was not resolved","In vivo relevance in mammalian physiology not yet established","Stoichiometry and topology of MRAP2–MCR complexes unknown"]},{"year":2013,"claim":"Whether MRAP2 has developmental physiological functions in vivo was resolved: zebrafish MRAP2 isoforms differentially tune MC4R ligand sensitivity to control growth during distinct developmental stages, providing the first in vivo demonstration that MRAP2 is a physiological regulator of energy balance.","evidence":"Zebrafish genetic models with binding/signaling assays and in vivo growth phenotyping","pmids":["23869017"],"confidence":"High","gaps":["Whether mammalian MRAP2 similarly controls MC4R in a developmental manner was not tested","Molecular basis for isoform-specific modulation of ligand affinity unknown"]},{"year":2017,"claim":"The scope of MRAP2 as a GPCR modulator was expanded beyond melanocortin receptors: MRAP2 interacts with and potentiates ghrelin receptor (GHSR1a) signaling in vitro and in vivo, while inhibiting OX1R and PKR1, demonstrating that MRAP2 is a multi-GPCR regulatory hub with receptor-specific outcomes.","evidence":"Co-IP and signaling assays for GHSR1a, OX1R, and PKR1; MRAP2 KO mice with neuronal activation phenotyping","pmids":["28959025","28939058"],"confidence":"High","gaps":["Structural basis for receptor-specific facilitation vs. inhibition unknown","Whether MRAP2 regulates GHSR1a and OX1R/PKR1 simultaneously in the same cell not addressed"]},{"year":2018,"claim":"The circuit-level question of where MRAP2 acts in the brain to control energy balance was addressed: overexpression of MRAP2 specifically in PVN MC4R neurons reduces food intake and increases energy expenditure, establishing the hypothalamic paraventricular nucleus as a key site of MRAP2 action.","evidence":"Stereotaxic AAV-mediated MRAP2 overexpression in Mc4r-Cre mice with metabolic and c-Fos phenotyping","pmids":["30352741"],"confidence":"High","gaps":["Contribution of other hypothalamic nuclei or peripheral tissues not dissected","Whether endogenous MRAP2 expression levels are rate-limiting in the PVN not determined"]},{"year":2020,"claim":"How MRAP2 achieves signaling bias was clarified: MRAP2 uses distinct domains to enhance Gαq-coupled signaling while blocking β-arrestin recruitment to GHSR1a, and separately requires MRAP2 in pancreatic δ cells for ghrelin-dependent insulin regulation, revealing both the molecular logic of biased signaling and a peripheral metabolic function.","evidence":"Domain-mapping mutagenesis with Gαq/β-arrestin assays; conditional δ-cell MRAP2 KO mice with calcium imaging and insulin secretion assays","pmids":["31911434","32535024"],"confidence":"High","gaps":["Specific MRAP2 residues mediating domain-selective effects on bias not identified","Whether β-arrestin suppression operates by the same mechanism across all GPCR partners not tested"]},{"year":2021,"claim":"The topology question — how MRAP2 dimers are arranged in the membrane — was resolved: MRAP2 forms symmetric antiparallel homodimers, and orientation of individual domains within the dimer is functionally important for MC4R regulation.","evidence":"Chimeric domain-inversion constructs with surface expression and cAMP assays","pmids":["34759891"],"confidence":"Medium","gaps":["Whether antiparallel dimer persists in the MRAP2–GPCR complex or dissociates upon receptor binding not determined","No high-resolution structural data confirming the dimer interface"]},{"year":2022,"claim":"The mechanism by which MRAP2 suppresses β-arrestin recruitment was identified: MRAP2 blocks GRK2 and PKC from phosphorylating GHSR1a at Ser252/Thr261 in the third intracellular loop, and separately MRAP2 interactions extend to MCHR1 and PKR2, broadening the receptor repertoire further.","evidence":"Phosphorylation-site mutagenesis and kinase interaction assays for GHSR1a; Co-IP/BiFC for MCHR1 and PKR2; obesity-linked R125H/R125C mutagenesis for PKR2","pmids":["35605660","35311242","36077245","38392222"],"confidence":"High","gaps":["Whether GRK2/PKC blockade is the universal mechanism for β-arrestin suppression at all MRAP2-regulated GPCRs not established","Structural basis for how MRAP2 sterically occludes kinase access unknown"]},{"year":2023,"claim":"A subcellular targeting function was discovered: MRAP2 is required for MC4R localization to primary cilia in neurons, and this ciliary targeting is essential for MC4R-dependent weight regulation, revealing a trafficking role beyond plasma membrane delivery.","evidence":"Conditional MRAP2 KO in MC4R neurons, ciliary immunofluorescence, body weight and feeding phenotyping","pmids":["36692018"],"confidence":"High","gaps":["Molecular mechanism of ciliary targeting (adaptor interactions, IFT involvement) not identified","Whether MRAP2 escorts other GPCRs to cilia not tested"]},{"year":2025,"claim":"A unifying structural and mechanistic framework emerged: MRAP2 engages MC4R, MC3R, and GHSR1a as 1:1 complexes via shared transmembrane contacts (MC4R TM5/6), disrupts GPCR homodimerization, and uses its C-terminal cytoplasmic domain to modulate constitutive activity; obesity-associated MRAP2 variants disrupt these conserved mechanisms across all tested receptors, and the receptor repertoire extends further to melatonin receptors.","evidence":"Single-molecule pull-down stoichiometry, FRET-based oligomerization, transmembrane alanine mutagenesis, multi-pathway signaling assays (cAMP, IP3, β-arrestin), structural homology modeling across MC4R/MC3R/GHSR1a; Co-IP/BiFC for melatonin receptors","pmids":["40998819","41401256","41722048","39807633","40510472"],"confidence":"High","gaps":["No experimental high-resolution structure of an MRAP2–GPCR complex exists","How MRAP2 achieves receptor-specific outcomes (enhancement vs. inhibition) through shared contact sites remains unresolved","In vivo validation of transmembrane contact-site mutations not performed"]},{"year":null,"claim":"Key unresolved questions include: the high-resolution structure of MRAP2–GPCR complexes, the molecular determinants that dictate whether MRAP2 enhances or inhibits a given receptor, whether MRAP2 simultaneously regulates multiple GPCRs in the same neuron, and how ciliary targeting is mechanistically achieved.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or crystal structure of any MRAP2–GPCR complex","Rules governing receptor-specific enhancement vs. inhibition not defined","Simultaneous multi-GPCR regulation in single cells not addressed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,4,11,12,13,14]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,5,9]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,7,17]},{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[9]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,4,11,12,13,14]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[6,7,17]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[7,14]}],"complexes":["MRAP2 antiparallel homodimer"],"partners":["MC4R","MC3R","MC2R","GHSR","OX1R","PROKR1","PROKR2","MCHR1"],"other_free_text":[]},"mechanistic_narrative":"MRAP2 is a single-pass transmembrane accessory protein that functions as a broad-spectrum modulator of G protein-coupled receptor signaling, trafficking, and oligomerization, with a central role in energy homeostasis. MRAP2 forms antiparallel homodimers and engages multiple GPCRs — including MC2R, MC3R, MC4R, GHSR1a, OX1R, PKR1/PKR2, MCHR1, and melatonin receptors — predominantly as 1:1 complexes that disrupt receptor homodimerization; it enhances G protein-mediated signaling (Gs-cAMP, Gαq) while suppressing β-arrestin recruitment by blocking GRK2/PKC-mediated receptor phosphorylation, with distinct MRAP2 domains governing these biased signaling outputs [PMID:31911434, PMID:35605660, PMID:41722048, PMID:41401256]. In neurons, MRAP2 is required for MC4R targeting to primary cilia and potentiates hypothalamic MC4R signaling to control food intake and energy expenditure; in pancreatic δ cells it enables ghrelin-GHSR1a signaling to regulate insulin secretion [PMID:36692018, PMID:30352741, PMID:32535024]. Loss-of-function MRAP2 variants are associated with human obesity and disrupt signaling enhancement across multiple receptor partners, with structural models identifying shared transmembrane contact sites on MC4R helices 5 and 6 as critical interaction interfaces [PMID:39807633, PMID:36077245, PMID:40998819]."},"prefetch_data":{"uniprot":{"accession":"Q96G30","full_name":"Melanocortin-2 receptor accessory protein 2","aliases":[],"length_aa":205,"mass_kda":23.5,"function":"Modulator of melanocortin receptor 4 (MC4R), a receptor involved in energy homeostasis. Plays a central role in the control of energy homeostasis and body weight regulation by increasing ligand-sensitivity of MC4R and MC4R-mediated generation of cAMP (By similarity). May also act as a negative regulator of MC2R: competes with MRAP for binding to MC2R and impairs the binding of corticotropin (ACTH) to MC2R. May also regulate activity of other melanocortin receptors (MC1R, MC3R and MC5R); however, additional evidence is required in vivo","subcellular_location":"Cell membrane; Endoplasmic reticulum membrane","url":"https://www.uniprot.org/uniprotkb/Q96G30/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MRAP2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MRAP2","total_profiled":1310},"omim":[{"mim_id":"615457","title":"BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18; BMIQ18","url":"https://www.omim.org/entry/615457"},{"mim_id":"615410","title":"MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN 2; MRAP2","url":"https://www.omim.org/entry/615410"},{"mim_id":"609196","title":"MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN; MRAP","url":"https://www.omim.org/entry/609196"},{"mim_id":"606641","title":"BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 1; BMIQ1","url":"https://www.omim.org/entry/606641"},{"mim_id":"155540","title":"MELANOCORTIN 3 RECEPTOR; MC3R","url":"https://www.omim.org/entry/155540"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"blood vessel","ntpm":97.2}],"url":"https://www.proteinatlas.org/search/MRAP2"},"hgnc":{"alias_symbol":["bA51G5.2"],"prev_symbol":["C6orf117"]},"alphafold":{"accession":"Q96G30","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96G30","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96G30-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96G30-F1-predicted_aligned_error_v6.png","plddt_mean":57.09},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MRAP2","jax_strain_url":"https://www.jax.org/strain/search?query=MRAP2"},"sequence":{"accession":"Q96G30","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96G30.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96G30/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96G30"}},"corpus_meta":[{"pmid":"19329486","id":"PMC_19329486","title":"MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19329486","citation_count":196,"is_preprint":false},{"pmid":"23869017","id":"PMC_23869017","title":"Developmental control of the melanocortin-4 receptor by MRAP2 proteins in zebrafish.","date":"2013","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23869017","citation_count":136,"is_preprint":false},{"pmid":"31700171","id":"PMC_31700171","title":"Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension.","date":"2019","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31700171","citation_count":80,"is_preprint":false},{"pmid":"28959025","id":"PMC_28959025","title":"MRAP2 regulates ghrelin receptor signaling and hunger sensing.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28959025","citation_count":65,"is_preprint":false},{"pmid":"28939058","id":"PMC_28939058","title":"Regions of MRAP2 required for the inhibition of orexin and prokineticin receptor signaling.","date":"2017","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28939058","citation_count":57,"is_preprint":false},{"pmid":"31911434","id":"PMC_31911434","title":"The GPCR accessory protein MRAP2 regulates both biased signaling and constitutive activity of the ghrelin receptor GHSR1a.","date":"2020","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/31911434","citation_count":50,"is_preprint":false},{"pmid":"28512117","id":"PMC_28512117","title":"The interaction of MC3R and MC4R with MRAP2, ACTH, α-MSH and AgRP in chickens.","date":"2017","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28512117","citation_count":48,"is_preprint":false},{"pmid":"32679290","id":"PMC_32679290","title":"Emerging roles of melanocortin receptor accessory proteins (MRAP and MRAP2) in physiology and pathophysiology.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32679290","citation_count":38,"is_preprint":false},{"pmid":"27106110","id":"PMC_27106110","title":"Loss of Mrap2 is associated with Sim1 deficiency and increased circulating cholesterol.","date":"2016","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27106110","citation_count":36,"is_preprint":false},{"pmid":"36692018","id":"PMC_36692018","title":"MRAP2 regulates energy homeostasis by promoting primary cilia localization of MC4R.","date":"2023","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/36692018","citation_count":30,"is_preprint":false},{"pmid":"26795956","id":"PMC_26795956","title":"Copy number variation (CNV) analysis and mutation analysis of the 6q14.1-6q16.3 genes SIM1 and MRAP2 in Prader Willi like patients.","date":"2016","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26795956","citation_count":29,"is_preprint":false},{"pmid":"31398355","id":"PMC_31398355","title":"Orange-spotted grouper melanocortin-4 receptor: Modulation of signaling by MRAP2.","date":"2019","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31398355","citation_count":27,"is_preprint":false},{"pmid":"33807040","id":"PMC_33807040","title":"MRAP2 Interaction with Melanocortin-4 Receptor in SnakeHead (Channa argus).","date":"2021","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33807040","citation_count":25,"is_preprint":false},{"pmid":"32535024","id":"PMC_32535024","title":"The Insulinostatic Effect of Ghrelin Requires MRAP2 Expression in δ Cells.","date":"2020","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/32535024","citation_count":21,"is_preprint":false},{"pmid":"22419722","id":"PMC_22419722","title":"Melanocortin 2 receptor-associated protein (MRAP) and MRAP2 in human adrenocortical tissues: regulation of expression and association with ACTH responsiveness.","date":"2012","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22419722","citation_count":21,"is_preprint":false},{"pmid":"30352741","id":"PMC_30352741","title":"Overexpression of melanocortin 2 receptor accessory protein 2 (MRAP2) in adult paraventricular MC4R neurons regulates energy intake and expenditure.","date":"2018","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30352741","citation_count":21,"is_preprint":false},{"pmid":"30856611","id":"PMC_30856611","title":"Pharmacological modulation of MRAP2 protein on melanocortin receptors in the sea lamprey.","date":"2019","source":"Endocrine connections","url":"https://pubmed.ncbi.nlm.nih.gov/30856611","citation_count":20,"is_preprint":false},{"pmid":"29524525","id":"PMC_29524525","title":"Evaluating the interactions between red stingray (Dasyatis akajei) melanocortin receptors and elephant shark (Callorhinchus milii) MRAP1 and MRAP2 following stimulation with either stingray ACTH(1-24) or stingray Des-Acetyl-αMSH: A pharmacological study in Chinese Hamster Ovary cells.","date":"2018","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/29524525","citation_count":19,"is_preprint":false},{"pmid":"24011068","id":"PMC_24011068","title":"Mrap2: an accessory protein linked to obesity.","date":"2013","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24011068","citation_count":18,"is_preprint":false},{"pmid":"27445982","id":"PMC_27445982","title":"Hypothesis and Theory: Revisiting Views on the Co-evolution of the Melanocortin Receptors and the Accessory Proteins, MRAP1 and MRAP2.","date":"2016","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27445982","citation_count":18,"is_preprint":false},{"pmid":"32578125","id":"PMC_32578125","title":"Study of LEP, MRAP2 and POMC genes as potential causes of severe obesity in Brazilian patients.","date":"2020","source":"Eating and weight disorders : EWD","url":"https://pubmed.ncbi.nlm.nih.gov/32578125","citation_count":17,"is_preprint":false},{"pmid":"31276671","id":"PMC_31276671","title":"Analyzing the signaling properties of gar (Lepisosteus oculatus) melanocortin receptors: Evaluating interactions with MRAP1 and MRAP2.","date":"2019","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31276671","citation_count":16,"is_preprint":false},{"pmid":"28888694","id":"PMC_28888694","title":"Analyzing the effects of co-expression of chick (Gallus gallus) melanocortin receptors with either chick MRAP1 or MRAP2 in CHO cells on sensitivity to ACTH(1-24) or ACTH(1-13)NH2: Implications for the avian HPA axis and avian melanocortin circuits in the hypothalamus.","date":"2017","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28888694","citation_count":16,"is_preprint":false},{"pmid":"30400043","id":"PMC_30400043","title":"Pharmacological modulation of two melanocortin-5 receptors by MRAP2 proteins in zebrafish.","date":"2019","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30400043","citation_count":14,"is_preprint":false},{"pmid":"24709359","id":"PMC_24709359","title":"Melanocortin receptor accessory protein 2 (MRAP2) interplays with the zebrafish melanocortin 1 receptor (MC1R) but has no effect on its pharmacological profile.","date":"2014","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24709359","citation_count":13,"is_preprint":false},{"pmid":"35605660","id":"PMC_35605660","title":"MRAP2 inhibits β-arrestin recruitment to the ghrelin receptor by preventing GHSR1a phosphorylation.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35605660","citation_count":11,"is_preprint":false},{"pmid":"32213301","id":"PMC_32213301","title":"Pharmacological properties of whale shark (Rhincodon typus) melanocortin-2 receptor and melancortin-5 receptor: Interaction with MRAP1 and MRAP2.","date":"2020","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32213301","citation_count":11,"is_preprint":false},{"pmid":"36077245","id":"PMC_36077245","title":"Arginine 125 Is an Essential Residue for the Function of MRAP2.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36077245","citation_count":9,"is_preprint":false},{"pmid":"35311242","id":"PMC_35311242","title":"Determination of the Interaction and Pharmacological Modulation of MCHR1 Signaling by the C-Terminus of MRAP2 Protein.","date":"2022","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/35311242","citation_count":9,"is_preprint":false},{"pmid":"38392222","id":"PMC_38392222","title":"MRAP2 Inhibits β-Arrestin-2 Recruitment to the Prokineticin Receptor 2.","date":"2024","source":"Current issues in molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38392222","citation_count":9,"is_preprint":false},{"pmid":"34425302","id":"PMC_34425302","title":"MC2R/MRAP2 activation could affect bovine ovarian steroidogenesis potential after ACTH treatment.","date":"2021","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/34425302","citation_count":9,"is_preprint":false},{"pmid":"39807633","id":"PMC_39807633","title":"Obesity-associated MRAP2 variants impair multiple MC4R-mediated signaling pathways.","date":"2025","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39807633","citation_count":8,"is_preprint":false},{"pmid":"37888144","id":"PMC_37888144","title":"A novel pathogenic variant in MRAP2 in an obese patient with successful outcome of bariatric surgery.","date":"2023","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37888144","citation_count":8,"is_preprint":false},{"pmid":"34653433","id":"PMC_34653433","title":"Regulation of melanocortin-5 receptor pharmacology by two isoforms of MRAP2 in ricefield eel (Monopterus albus).","date":"2021","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34653433","citation_count":7,"is_preprint":false},{"pmid":"34759891","id":"PMC_34759891","title":"Functional Characterization of the Internal Symmetry of MRAP2 Antiparallel Homodimer.","date":"2021","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34759891","citation_count":6,"is_preprint":false},{"pmid":"30951854","id":"PMC_30951854","title":"MRAP2 regulates endometrial receptivity and function.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/30951854","citation_count":5,"is_preprint":false},{"pmid":"33559170","id":"PMC_33559170","title":"Elucidation of the dimeric interplay of dual MRAP2 proteins in the zebrafish.","date":"2021","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33559170","citation_count":5,"is_preprint":false},{"pmid":"35741395","id":"PMC_35741395","title":"Reversion of MRAP2 Protein Sequence Generates a Functional Novel Pharmacological Modulator for MC4R Signaling.","date":"2022","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/35741395","citation_count":5,"is_preprint":false},{"pmid":"21139347","id":"PMC_21139347","title":"siRNA-mediated knockdown of the melanocortin 2 receptor accessory protein 2 (MRAP2) gene confers resistance to methylmercury on HEK293 cells.","date":"2010","source":"The Journal of toxicological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21139347","citation_count":5,"is_preprint":false},{"pmid":"40998819","id":"PMC_40998819","title":"MRAP2 modifies the signaling and oligomerization state of the melanocortin-4 receptor.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40998819","citation_count":4,"is_preprint":false},{"pmid":"39574659","id":"PMC_39574659","title":"The MRAP2 accessory protein directly interacts with melanocortin-3 receptor to enhance signaling.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39574659","citation_count":4,"is_preprint":false},{"pmid":"35447133","id":"PMC_35447133","title":"Analyzing the Hypothalamus/Pituitary/Interrenal axis of the neopterygian fish, Lepisosteus oculatus: Co-localization of MC2R, MC5R, MRAP1, and MRAP2 in interrenal cells.","date":"2022","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/35447133","citation_count":4,"is_preprint":false},{"pmid":"34607718","id":"PMC_34607718","title":"Pharmacological properties of whale shark (Rhincodon typus) melanocortin-2 receptor and melancortin-5 receptor: Interaction with MRAP1 and MRAP2.","date":"2021","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34607718","citation_count":4,"is_preprint":false},{"pmid":"41401256","id":"PMC_41401256","title":"The accessory protein MRAP2 directly interacts with melanocortin-3 receptor to enhance signaling.","date":"2025","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/41401256","citation_count":3,"is_preprint":false},{"pmid":"37454980","id":"PMC_37454980","title":"Molecular and pharmacological analysis of the melanocortin-2 receptor and its accessory proteins Mrap1 and Mrap2 in a Squalomorph shark, the Pacific spiny dogfish.","date":"2023","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37454980","citation_count":2,"is_preprint":false},{"pmid":"41040264","id":"PMC_41040264","title":"MRAP2 potentiates GPCR signaling by conserved mechanisms that are disrupted by obesity-associated genetic variants.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41040264","citation_count":1,"is_preprint":false},{"pmid":"41722048","id":"PMC_41722048","title":"MRAP2 potentiates GPCR signaling by conserved mechanisms that are disrupted by obesity-associated genetic variants.","date":"2026","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/41722048","citation_count":1,"is_preprint":false},{"pmid":"40510472","id":"PMC_40510472","title":"Pharmacological modulation of MRAP2 protein on murine melatonin receptor signaling.","date":"2025","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/40510472","citation_count":0,"is_preprint":false},{"pmid":"36455644","id":"PMC_36455644","title":"Pharmacology of orange-spotted grouper (Epinephelus coioides) melanocortin-5 receptor and its modulation by Mrap2.","date":"2022","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/36455644","citation_count":0,"is_preprint":false},{"pmid":"41758604","id":"PMC_41758604","title":"Functional characterisation of obesity-associated MRAP2 variants on MC4R and GHSR signalling.","date":"2026","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41758604","citation_count":0,"is_preprint":false},{"pmid":"41596694","id":"PMC_41596694","title":"Association of Mutations in the Melanocortin-2 Receptor Accessory Protein 2 Gene (MRAP2) and Obesity: A Systematic Review and Meta-Analysis.","date":"2026","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41596694","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.13.25327505","title":"The role of common and rare genetic variation on adiposity across childhood","date":"2025-05-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.13.25327505","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":26351,"output_tokens":4273,"usd":0.071574},"stage2":{"model":"claude-opus-4-6","input_tokens":7854,"output_tokens":3079,"usd":0.174368},"total_usd":0.245942,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2009,\n      \"finding\": \"MRAP2 interacts with all five melanocortin receptors (MC1R–MC5R). This interaction enables MC2R surface expression and signaling, while reducing MC1R, MC3R, MC4R, and MC5R responsiveness to NDP-MSH — establishing MRAP2 as a bidirectional regulator of the MCR family.\",\n      \"method\": \"Co-immunoprecipitation, cell surface expression assays, cAMP signaling assays in heterologous cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction and functional readouts replicated across all five receptors in a highly-cited foundational paper\",\n      \"pmids\": [\"19329486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In zebrafish, MRAP2a binds MC4R and reduces ligand binding affinity for α-MSH, thereby blocking MC4R activity and stimulating growth during larval development, while MRAP2b also binds MC4R but increases ligand sensitivity, enhancing responsiveness to α-MSH once feeding begins — demonstrating developmental control of MC4R by MRAP2 isoforms.\",\n      \"method\": \"Zebrafish genetic model, cell culture binding and signaling assays, in vivo growth phenotyping\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro binding and signaling combined with in vivo zebrafish genetic evidence, highly cited\",\n      \"pmids\": [\"23869017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MRAP2 interacts with the ghrelin receptor GHSR1a and potentiates ghrelin-stimulated G protein signaling both in vitro and in vivo. In MRAP2-deficient mice, fasting fails to activate AgRP neurons and the orexigenic effect of ghrelin is lost.\",\n      \"method\": \"Co-immunoprecipitation (MRAP2–GHSR1a interaction), in vitro cAMP/signaling assays, MRAP2 knockout mouse model with neuronal activation readout\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — interaction confirmed by Co-IP, functional consequence demonstrated in vitro and in vivo with KO mice\",\n      \"pmids\": [\"28959025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MRAP2 interacts with and inhibits the trafficking and signaling of orexin receptor 1 (OX1R) and prokineticin receptor 1 (PKR1). Specific regions of MRAP2 are required for regulation of OX1R and PKR1.\",\n      \"method\": \"Co-immunoprecipitation, cell surface trafficking assays, domain-mapping experiments with MRAP2 truncation mutants\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — interaction and domain mapping shown in vitro; single lab\",\n      \"pmids\": [\"28939058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MRAP2 inhibits the constitutive activity of GHSR1a, enhances G protein-dependent (Gαq) signaling in response to ghrelin, and blocks β-arrestin recruitment and signaling. The effects on Gαq and β-arrestin pathways involve distinct regions of MRAP2, establishing biased signaling modulation by an accessory protein.\",\n      \"method\": \"Gαq and β-arrestin signaling assays, domain-mapping of MRAP2, constitutive activity assays in heterologous cells\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal signaling assays with domain-mapping mutagenesis in a single rigorous study\",\n      \"pmids\": [\"31911434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MRAP2 is expressed in pancreatic islet δ cells and is required for ghrelin to elicit a calcium response in those cells. Global and δ-cell-targeted deletion of MRAP2 abrogates the insulinostatic effect of ghrelin, establishing MRAP2 as a regulator of insulin secretion via δ-cell GHSR1a signaling.\",\n      \"method\": \"Calcium imaging in δ cells, global and conditional (δ cell-specific) MRAP2 knockout mouse models, insulin secretion assays\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with specific cellular and physiological phenotype using multiple mouse models\",\n      \"pmids\": [\"32535024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MRAP2 inhibits β-arrestin recruitment to GHSR1a by blocking GRK2 and PKC from phosphorylating the receptor at Ser252 and Thr261 in the third intracellular loop. The C-terminal tail of GHSR1a is not essential for β-arrestin interaction.\",\n      \"method\": \"Phosphorylation site mutagenesis, GRK2/PKC interaction assays, β-arrestin recruitment assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — active-site/phosphorylation-site mutagenesis with mechanistic follow-up identifying the kinases blocked by MRAP2\",\n      \"pmids\": [\"35605660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Arginine 125 in MRAP2 is essential for protein conformation, dimer formation, and PKR2 binding. Human obesity-associated mutations R125H and R125C disrupt these functions.\",\n      \"method\": \"MRAP2 mutant characterization (R125H, R125C), dimerization assays, PKR2 co-immunoprecipitation, comparison with mouse MRAP2\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional readouts; single lab\",\n      \"pmids\": [\"36077245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MRAP2 interacts with melanin-concentrating hormone receptor 1 (MCHR1) as shown by co-immunoprecipitation and bimolecular fluorescence complementation, and inhibits MCHR1 signaling. The C-terminal domain of MRAP2 is required for pharmacological modulation of intracellular Ca2+ cascades and membrane transport of MCHR1.\",\n      \"method\": \"Co-immunoprecipitation, BiFC assay, functional truncation mapping, intracellular Ca2+ signaling assay\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods confirming interaction and domain requirements; single lab\",\n      \"pmids\": [\"35311242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MRAP2 is critical for the ciliary localization of MC4R in neurons. Loss of MRAP2 disrupts MC4R targeting to the primary cilium, and this ciliary localization is essential for the weight-regulating function of MC4R neurons and long-term energy homeostasis.\",\n      \"method\": \"Conditional mouse models (MRAP2 KO in MC4R neurons), live imaging/immunofluorescence of primary cilia localization, body weight and food intake phenotyping\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional consequence demonstrated in vivo using conditional KO mice\",\n      \"pmids\": [\"36692018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MRAP2 inhibits β-arrestin-2 recruitment to prokineticin receptor 2 (PKR2) without preventing receptor internalization, modulating PKR2-mediated β-arrestin signaling pathways.\",\n      \"method\": \"β-arrestin recruitment assays, receptor internalization assays, signaling pathway analysis\",\n      \"journal\": \"Current issues in molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined molecular mechanism with clear readouts; single lab\",\n      \"pmids\": [\"38392222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MRAP2 co-expression increases MC4R G protein-mediated signaling, impairs β-arrestin2 recruitment and receptor internalization, and disrupts MC4R oligomers, increasing the proportion of monomeric MC4R. A structural homology model identifies MRAP2 interaction sites relevant for receptor activation.\",\n      \"method\": \"cAMP signaling assays, β-arrestin2 recruitment assays, FRET/fluorescence-based oligomerization assays, structural homology modeling\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including structural model, signaling, and oligomerization assays in a single rigorous study\",\n      \"pmids\": [\"40998819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MRAP2 directly interacts with MC3R with 1:1 stoichiometry, enhances MC3R cAMP signaling, impairs β-arrestin recruitment, and reduces MC3R internalization. Alanine mutagenesis of five MRAP2 and three MC3R transmembrane residues identified by structural homology modeling disrupts these effects. Obesity-associated MRAP2 variants fail to enhance MC3R signaling.\",\n      \"method\": \"Single-molecule pull-down (SiMPull), fluorescence photobleaching stoichiometry, cAMP assay, β-arrestin recruitment assay, internalization assay, transmembrane alanine mutagenesis, structural homology modeling\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — single-molecule interaction assays with stoichiometry, mutagenesis, and multiple functional readouts in peer-reviewed study\",\n      \"pmids\": [\"41401256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MRAP2 interacts with MC4R, MC3R, and GHSR1a preferentially as 1:1 complexes (disrupting GPCR homodimerization), using shared receptor transmembrane region contacts to promote G protein signaling and impair β-arrestin-2 recruitment. Deletion of the MRAP2 cytoplasmic C-terminal region impairs GPCR signaling by modulating receptor constitutive activity. Obesity-associated MRAP2 variants modify constitutive activity of all three GPCRs.\",\n      \"method\": \"Single-molecule pull-down stoichiometry, GPCR homodimerization assays, domain deletion mutagenesis, constitutive activity assays, β-arrestin-2 recruitment assays for three receptors\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods across three receptors establishing conserved mechanism; rigorous domain mapping\",\n      \"pmids\": [\"41722048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Obesity-associated MRAP2 variants impair multiple MC4R signaling pathways including Gs-cAMP and Gq-IP3; seven variants impair cAMP signaling and nine impair IP3 signaling. Four mutations in the MRAP2 C-terminus affect MC4R internalization. Structural models predict MRAP2 interacts with MC4R transmembrane helices 5 and 6, and mutagenesis of these contact sites impairs MRAP2-facilitated MC4R signaling.\",\n      \"method\": \"cAMP signaling assay, IP3 signaling assay, internalization assay, cell surface expression assay, structural homology modeling, contact-site alanine mutagenesis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — comprehensive multi-pathway functional analysis with structural modeling and mutagenesis validation of 12 MRAP2 variants\",\n      \"pmids\": [\"39807633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Overexpression of MRAP2 specifically in PVN MC4R-expressing neurons reduces food intake, increases energy expenditure, and enhances neuronal activation at baseline and after MC3R/MC4R agonist treatment, demonstrating a site-specific role for MRAP2 in potentiating MC4R signaling in the hypothalamic paraventricular nucleus.\",\n      \"method\": \"Stereotaxic AAV-mediated MRAP2 overexpression in Mc4r-cre mice (PVN-targeted), metabolic phenotyping (food intake, energy expenditure, glucose metabolism), c-Fos neuronal activation\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — circuit-level gain-of-function with defined cellular target and multiple physiological readouts\",\n      \"pmids\": [\"30352741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MRAP2 interacts with melatonin receptors MTNR1A and MTNR1B, inhibits their constitutive activity, and enhances maximal agonist potency. MRAP2 suppresses membrane trafficking of MTNR1A but promotes surface trafficking of MTNR1B.\",\n      \"method\": \"Co-immunoprecipitation, BiFC assay, GloSensor luminescence (Gi signaling), fixed-cell ELISA (surface expression)\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods for a novel receptor interaction; single lab\",\n      \"pmids\": [\"40510472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MRAP2 forms a symmetric antiparallel homodimer topology on the plasma membrane. Inversion of individual MRAP2 domains (N-terminal, transmembrane, C-terminal) via chimeric constructs shows proper dimer assembly but alters regulatory profile on MC4R surface expression and ligand-stimulated cAMP signaling, demonstrating functional importance of domain orientation within the dimer.\",\n      \"method\": \"Chimeric domain-inversion constructs, cell surface expression assays, cAMP signaling assays, homodimer characterization\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain-inversion mutagenesis with multiple functional readouts establishes topology-function relationship; single lab\",\n      \"pmids\": [\"34759891\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MRAP2 is a single-pass transmembrane protein that forms antiparallel homodimers and interacts (predominantly as 1:1 complexes) with multiple GPCRs — including MC2R, MC3R, MC4R, GHSR1a, OX1R, PKR1/PKR2, MCHR1, and melatonin receptors — using shared transmembrane contact sites (e.g., MC4R TM5/6) to enhance G protein-mediated signaling, suppress β-arrestin recruitment (partly by blocking GRK2/PKC-mediated receptor phosphorylation), disrupt GPCR homodimerization, and in neurons promote MC4R targeting to primary cilia, with the C-terminal cytoplasmic region modulating constitutive GPCR activity; loss-of-function MRAP2 variants associated with human obesity disrupt these shared regulatory mechanisms across multiple receptor partners.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MRAP2 is a single-pass transmembrane accessory protein that functions as a broad-spectrum modulator of G protein-coupled receptor signaling, trafficking, and oligomerization, with a central role in energy homeostasis. MRAP2 forms antiparallel homodimers and engages multiple GPCRs — including MC2R, MC3R, MC4R, GHSR1a, OX1R, PKR1/PKR2, MCHR1, and melatonin receptors — predominantly as 1:1 complexes that disrupt receptor homodimerization; it enhances G protein-mediated signaling (Gs-cAMP, Gαq) while suppressing β-arrestin recruitment by blocking GRK2/PKC-mediated receptor phosphorylation, with distinct MRAP2 domains governing these biased signaling outputs [PMID:31911434, PMID:35605660, PMID:41722048, PMID:41401256]. In neurons, MRAP2 is required for MC4R targeting to primary cilia and potentiates hypothalamic MC4R signaling to control food intake and energy expenditure; in pancreatic δ cells it enables ghrelin-GHSR1a signaling to regulate insulin secretion [PMID:36692018, PMID:30352741, PMID:32535024]. Loss-of-function MRAP2 variants are associated with human obesity and disrupt signaling enhancement across multiple receptor partners, with structural models identifying shared transmembrane contact sites on MC4R helices 5 and 6 as critical interaction interfaces [PMID:39807633, PMID:36077245, PMID:40998819].\",\n  \"teleology\": [\n    {\n      \"year\": 2009,\n      \"claim\": \"The question of whether MRAP2 regulates receptors beyond MC2R was answered: MRAP2 interacts with all five melanocortin receptors and bidirectionally modulates their signaling, establishing it as a general MCR accessory protein rather than an MC2R-specific chaperone.\",\n      \"evidence\": \"Co-immunoprecipitation, surface expression, and cAMP assays across MC1R–MC5R in heterologous cells\",\n      \"pmids\": [\"19329486\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of differential regulation (facilitation of MC2R vs. inhibition of MC1R/MC3R–MC5R) was not resolved\", \"In vivo relevance in mammalian physiology not yet established\", \"Stoichiometry and topology of MRAP2–MCR complexes unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Whether MRAP2 has developmental physiological functions in vivo was resolved: zebrafish MRAP2 isoforms differentially tune MC4R ligand sensitivity to control growth during distinct developmental stages, providing the first in vivo demonstration that MRAP2 is a physiological regulator of energy balance.\",\n      \"evidence\": \"Zebrafish genetic models with binding/signaling assays and in vivo growth phenotyping\",\n      \"pmids\": [\"23869017\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian MRAP2 similarly controls MC4R in a developmental manner was not tested\", \"Molecular basis for isoform-specific modulation of ligand affinity unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The scope of MRAP2 as a GPCR modulator was expanded beyond melanocortin receptors: MRAP2 interacts with and potentiates ghrelin receptor (GHSR1a) signaling in vitro and in vivo, while inhibiting OX1R and PKR1, demonstrating that MRAP2 is a multi-GPCR regulatory hub with receptor-specific outcomes.\",\n      \"evidence\": \"Co-IP and signaling assays for GHSR1a, OX1R, and PKR1; MRAP2 KO mice with neuronal activation phenotyping\",\n      \"pmids\": [\"28959025\", \"28939058\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for receptor-specific facilitation vs. inhibition unknown\", \"Whether MRAP2 regulates GHSR1a and OX1R/PKR1 simultaneously in the same cell not addressed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The circuit-level question of where MRAP2 acts in the brain to control energy balance was addressed: overexpression of MRAP2 specifically in PVN MC4R neurons reduces food intake and increases energy expenditure, establishing the hypothalamic paraventricular nucleus as a key site of MRAP2 action.\",\n      \"evidence\": \"Stereotaxic AAV-mediated MRAP2 overexpression in Mc4r-Cre mice with metabolic and c-Fos phenotyping\",\n      \"pmids\": [\"30352741\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of other hypothalamic nuclei or peripheral tissues not dissected\", \"Whether endogenous MRAP2 expression levels are rate-limiting in the PVN not determined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"How MRAP2 achieves signaling bias was clarified: MRAP2 uses distinct domains to enhance Gαq-coupled signaling while blocking β-arrestin recruitment to GHSR1a, and separately requires MRAP2 in pancreatic δ cells for ghrelin-dependent insulin regulation, revealing both the molecular logic of biased signaling and a peripheral metabolic function.\",\n      \"evidence\": \"Domain-mapping mutagenesis with Gαq/β-arrestin assays; conditional δ-cell MRAP2 KO mice with calcium imaging and insulin secretion assays\",\n      \"pmids\": [\"31911434\", \"32535024\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific MRAP2 residues mediating domain-selective effects on bias not identified\", \"Whether β-arrestin suppression operates by the same mechanism across all GPCR partners not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The topology question — how MRAP2 dimers are arranged in the membrane — was resolved: MRAP2 forms symmetric antiparallel homodimers, and orientation of individual domains within the dimer is functionally important for MC4R regulation.\",\n      \"evidence\": \"Chimeric domain-inversion constructs with surface expression and cAMP assays\",\n      \"pmids\": [\"34759891\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether antiparallel dimer persists in the MRAP2–GPCR complex or dissociates upon receptor binding not determined\", \"No high-resolution structural data confirming the dimer interface\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"The mechanism by which MRAP2 suppresses β-arrestin recruitment was identified: MRAP2 blocks GRK2 and PKC from phosphorylating GHSR1a at Ser252/Thr261 in the third intracellular loop, and separately MRAP2 interactions extend to MCHR1 and PKR2, broadening the receptor repertoire further.\",\n      \"evidence\": \"Phosphorylation-site mutagenesis and kinase interaction assays for GHSR1a; Co-IP/BiFC for MCHR1 and PKR2; obesity-linked R125H/R125C mutagenesis for PKR2\",\n      \"pmids\": [\"35605660\", \"35311242\", \"36077245\", \"38392222\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GRK2/PKC blockade is the universal mechanism for β-arrestin suppression at all MRAP2-regulated GPCRs not established\", \"Structural basis for how MRAP2 sterically occludes kinase access unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A subcellular targeting function was discovered: MRAP2 is required for MC4R localization to primary cilia in neurons, and this ciliary targeting is essential for MC4R-dependent weight regulation, revealing a trafficking role beyond plasma membrane delivery.\",\n      \"evidence\": \"Conditional MRAP2 KO in MC4R neurons, ciliary immunofluorescence, body weight and feeding phenotyping\",\n      \"pmids\": [\"36692018\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of ciliary targeting (adaptor interactions, IFT involvement) not identified\", \"Whether MRAP2 escorts other GPCRs to cilia not tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A unifying structural and mechanistic framework emerged: MRAP2 engages MC4R, MC3R, and GHSR1a as 1:1 complexes via shared transmembrane contacts (MC4R TM5/6), disrupts GPCR homodimerization, and uses its C-terminal cytoplasmic domain to modulate constitutive activity; obesity-associated MRAP2 variants disrupt these conserved mechanisms across all tested receptors, and the receptor repertoire extends further to melatonin receptors.\",\n      \"evidence\": \"Single-molecule pull-down stoichiometry, FRET-based oligomerization, transmembrane alanine mutagenesis, multi-pathway signaling assays (cAMP, IP3, β-arrestin), structural homology modeling across MC4R/MC3R/GHSR1a; Co-IP/BiFC for melatonin receptors\",\n      \"pmids\": [\"40998819\", \"41401256\", \"41722048\", \"39807633\", \"40510472\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No experimental high-resolution structure of an MRAP2–GPCR complex exists\", \"How MRAP2 achieves receptor-specific outcomes (enhancement vs. inhibition) through shared contact sites remains unresolved\", \"In vivo validation of transmembrane contact-site mutations not performed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the high-resolution structure of MRAP2–GPCR complexes, the molecular determinants that dictate whether MRAP2 enhances or inhibits a given receptor, whether MRAP2 simultaneously regulates multiple GPCRs in the same neuron, and how ciliary targeting is mechanistically achieved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or crystal structure of any MRAP2–GPCR complex\", \"Rules governing receptor-specific enhancement vs. inhibition not defined\", \"Simultaneous multi-GPCR regulation in single cells not addressed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 4, 11, 12, 13, 14]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 5, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 7, 17]},\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [0, 2, 4, 11, 12, 13, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 4, 11, 12, 13, 14]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [6, 7, 17]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 14]}\n    ],\n    \"complexes\": [\n      \"MRAP2 antiparallel homodimer\"\n    ],\n    \"partners\": [\n      \"MC4R\",\n      \"MC3R\",\n      \"MC2R\",\n      \"GHSR\",\n      \"OX1R\",\n      \"PROKR1\",\n      \"PROKR2\",\n      \"MCHR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}